New imaging procedures in thyroid-associated ophthalmopathy

References

• Wall J R, Salvi M, Bernard N F, Boucher A, Haegert D. Thyroidassociated ophthalmopathy—a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12: 150–153
   PubMedGoogle Scholar
• Wall J R. Pathogenesis and management of thyroid associated ophthalmopathy: an update. Thyroid Today 1991; 14: 1–9
   Google Scholar
• van der Gaag R, Schmidt E D, Koornneef L. Retrobulbar histology and immunohistochemistry in endocrine ophthalmopathy. Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects, G Kahaly. Karger, Basel 1993; 1–10
   Google Scholar
• Kahaly G, Hansen C, Felke B, Dienes H P. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol 1994; 73: 53–62
   PubMedGoogle Scholar
• Kroll A J, Kuwabara T. Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy. Arch Ophthalmol 1966; 76: 244–257
   PubMedGoogle Scholar
• Trokel S L, Jakobiec F A. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology 1981; 88: 553–564
   PubMed Web of Science ®Google Scholar
• Just M, Thelen M. Tissue characterisation using NMR tissue parameters: results in 160 patients with brain tumors. Radiology 1988; 169: 779–785
   PubMedGoogle Scholar
• Hosten N, Sander B, Cordes M, Schubert C J, Schörner W, Felix R. Graves' ophthalmopathy: MR imaging of the orbits. Radiology 1989; 172: 759–762
   PubMed Web of Science ®Google Scholar
• Sreedharan S P, Kodama K T, Peterson K E, Goetzl E J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 1989; 264: 949–953
   PubMed Web of Science ®Google Scholar
• Lamberts S WJ, Bakker W H, Reubi J C, Krenning E P. Somatostatin receptor imaging in the localisation of endocrine tumors. N Engl J Med 1990; 323: 1246–1249
   PubMed Web of Science ®Google Scholar
• Krenning E P, Bakker W H, Kooij P PM, et al. Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe1)-octreotide in man: metabolism, dosimetry and comparison with (123-I-Tyr-3)-octreotide. J Nucl Med 1992; 33: 652–658
   PubMed Web of Science ®Google Scholar
• Classification of eye changes of Graves' disease. Thyroid 1992; 2: 235–236
   PubMed Web of Science ®Google Scholar
• Kahaly G, Diaz M, Hahn K, Beyer J, Bockisch A. Indium-111-Pentetreotide scintigraphy in Graves' ophthalmopathy. J Nucl Med 1995; 36: 550–554
   PubMedGoogle Scholar
• Kahaly G, Diaz M, Just M, Beyer J, Lieb W. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy. Thyroid 1995; 5: 107–111
   PubMedGoogle Scholar
• Wiersinga W M. Immunosuppression in endocrine ophthalmopathy. Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects, G Kahaly. Karger, Basel 1993; 120–130
   Google Scholar
• Krenning E P, Oei H Y, Kooij P PM, et al. Thyroid and orbital radiolabelled somatostatin accumulation in Graves' disease and Graves' ophthalmopathy. J Nucl Med 1992; 33: 894, (Abstract)
   Google Scholar
• Postema P TE, Krenning E P, Wijngaarde R, et al. ‘111In-DTPA-D-Phe1’ Octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity. J Clin Endocrinol Metabol 1994; 79: 1845–1851
   PubMedGoogle Scholar
• Krenning E P, Postema P TE, Wijngaarde R, et al. ‘In-111-DTPA-D-Phe-1’ Octreotide scintigraphy in thyroidal and orbital Graves' disease: follow-up during treatment. Thyroid 1995; 5(suppl 1)S-183, (Abstract)
   Google Scholar
• Moncayo R, Baldissera I, Metzler R, Decristoforo C, Riccabona G. Octreoscan in the evaluation of active Graves' ophthalmopathy. Thyroid 1995; 5(supp. 1)S-69, (Abstract)
   Google Scholar
• Kahaly G, Stover C, Otto E, Beyer J, Schuler M. Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity 1992; 13: 81–88
   PubMed Web of Science ®Google Scholar
• Kahaly G, Stover C, Beyer J, Otto E. In vitro synthesis of glycosaminoglycans in endocrine ophthalmopathy. Acta Endocrinol 1992; 127: 397–402
   PubMedGoogle Scholar
• Schuler M, Hansen C, Winand R, Stover C, Otto E, Beyer J, Kahaly G. Urinary and plasma glycosaminoglycans in endocrine ophthalmopathy. Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects, G Kahaly. Karger, Basel 1993; 58–67
   Google Scholar
• Kahaly G, Hansen C, Stover C, Beyer J, Otto E. Glycosaminoglycan antibodies in endocrine ophthalmopathy. Horm Met Res 1993; 25: 637–639
   PubMedGoogle Scholar
• Kahaly G, Hansen C, Beyer J, Winand R. Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994; 17: 45–50
   PubMedGoogle Scholar
• Kahaly G, Hansen C, Stover C, Kuhleman K, Beyer J, Otto E. Glycosaminoglycans and endocrine orbitopathy. Exp Clin Endocrinol 1994; 102: 151–161
   Google Scholar
• Stover C, Otto E, Beyer J, Kahaly G. Cellular immunity and retrobulbar fibroblasts in Graves' ophthalmopathy. Thyroid 1994; 4: 161–165
   PubMed Web of Science ®Google Scholar
• Just M, Kahaly G, Higer H P, et al. Graves' ophthalmopathy. role of MR imaging in radiation therapy. Radiology 1991; 179: 187–190
   PubMed Web of Science ®Google Scholar
• Kahaly G, Just M, Lieb M, Stover C, Beyer J, Rösier H P. Magnetic resonance imaging in therapy of endocrine ophthalmopathy. Acta Endocrinol 1992; 126(suppl 4)151
   Google Scholar
• Hiromatsu Y, Kojima K, Ishisaka N, et al. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 1992; 2: 299–305
   PubMedGoogle Scholar
• Ohnishi T, Noguchi S, Murakami N, et al. Extraocular muscles in Graves' ophthalmopathy: usefulness of T2 relaxation time measurements. Radiology 1994; 190: 857–862
   PubMed Web of Science ®Google Scholar
• Utech C, Khatibnia U, Winter P, Wulle K. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid 1995; 5: 185–193
   PubMedGoogle Scholar
• Prummel M F, Suttorp-Schulten M SA, Wiersinga W M, Verbeek A M, Mourits M P, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology 1993; 100: 556–561
   PubMed Web of Science ®Google Scholar
• Kahaly G, Müller-Forell W, Beyer J. CT measurements of retrobulbar fat volume in endocrine orbitopathy. Acta Endocrinol 1991; 124: 94
   Google Scholar